OpenURL Connection Search

Select item for more details and to access through your institution.

Intravenous arketamine for treatment-resistant depression: open-label pilot study.
Published in:
European Archives of Psychiatry & Clinical Neuroscience, 2021, v. 271, n. 3, p. 577, doi. 10.1007/s00406-020-01110-5
By:
- Leal, Gustavo C.;
- Bandeira, Igor D.;
- Correia-Melo, Fernanda S.;
- Telles, Manuela;
- Mello, Rodrigo P.;
- Vieira, Flavia;
- Lima, Cassio S.;
- Jesus-Nunes, Ana Paula;
- Guerreiro-Costa, Lívia N. F.;
- Marback, Roberta F.;
- Caliman-Fontes, Ana Teresa;
- Marques, Breno L. S.;
- Bezerra, Marília L. O.;
- Dias-Neto, Alberto L.;
- Silva, Samantha S.;
- Sampaio, Aline S.;
- Sanacora, Gerard;
- Turecki, Gustavo;
- Loo, Colleen;
- Lacerda, Acioly L. T.
Publication type:
Article
Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1.
Published in:
Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2020, v. 19, n. 2, p. 166, doi. 10.1016/j.aohep.2019.09.005
By:
- Henrique-Araújo, Ricardo;
- Quarantini, Lucas C.;
- Morais-de-Jesus, Mychelle;
- Jesus-Nunes, Ana Paula;
- Dantas-Duarte, Adriana;
- Caribé, André C.;
- Argolo, Felipe C.;
- Marback, Roberta F.;
- Costa, Tarciana V.;
- de Oliveira, Irismar Reis
Publication type:
Article
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression.
Published in:
Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 4, p. 1, doi. 10.1002/hup.2836
By:
- Jesus‐Nunes, Ana Paula;
- Leal, Gustavo C.;
- Correia‐Melo, Fernanda S.;
- Vieira, Flávia;
- Mello, Rodrigo P.;
- Caliman‐Fontes, Ana Teresa;
- Echegaray, Mariana V. F.;
- Marback, Roberta F.;
- Guerreiro‐Costa, Lívia N. F.;
- Souza‐Marques, Breno;
- Santos‐Lima, Cassio;
- Souza, Lucca S.;
- Bandeira, Igor D.;
- Kapczinski, Flavio;
- Lacerda, Acioly L. T.;
- Quarantini, Lucas C.
Publication type:
Article

Found: 3

Intravenous arketamine for treatment-resistant depression: open-label pilot study.

Comparative study of impulsiveness and risk behaviors among infected individuals with hepatitis C virus and human T-cell lymphotropic virus type 1.

Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression.